Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Fort Myers Beach is becoming the front line of a new Florida—one shaped by hurricane devastation, soaring insurance premiums, and rapid gentrification. Three years after Hurricane Ian, residents are still battling massive rebuilding costs and insurance bills that now exceed $5,700 a year on average, with flood insurance reaching $10,000 for some families. Long-time locals, small businesses, and service workers are being priced out as wealthy investors move in, transforming once-affordable coastal communities. Real estate professionals warn that foreclosures may rise if economic pressures continue, signaling a pivotal moment for Florida’s housing market and the professionals who serve it.
Economic uncertainty, AI disruption, slowing population growth, and rising portfolio risk are reshaping commercial real estate heading into 2026. A new report unveiled at NAR NXT highlights the forces that will reward informed professionals — and challenge those who aren’t prepared. From fiscal policy and shifting capital flows to tech transformation and housing shortages, the landscape is evolving fast. Cameron Academy breaks down the key issues so real estate, mortgage, finance, and insurance professionals can stay ahead of the curve.
A sudden federal shutdown of FEMA’s BRIC resiliency program has left cities and commercial property owners scrambling, exposing billions in real estate to rising climate threats. With nearly a billion dollars in mitigation funding clawed back and extreme weather intensifying, insurance premiums are expected to surge and coverage may shrink — placing new pressure on markets like Florida and New York.
A new Florida Senate bill aims to stop cities and counties from blocking residential developments over vague “compatibility” concerns. Supporters say the measure would speed up homebuilding and ease housing shortages, while opponents argue it strips communities of essential oversight and could accelerate growth without proper planning. The proposal could reshape development timelines and land-use decisions statewide, making it a major issue for real estate professionals to watch.
Cape Coral–Fort Myers has officially moved into buyer-friendly territory, with homes now sitting a median 119 days on the market—far longer than both the Florida and U.S. averages. Rising inventory, a 36.9 percent price‑reduction rate, and slower absorption compared to accumulated supply are giving buyers more leverage and time to negotiate, signaling a meaningful reset in this once‑fast‑moving Florida market.
Kansas City’s commercial real estate sector is finally turning a corner after several years of sluggish activity. Retail is leading the rebound, while multifamily and industrial properties are gaining traction as pricing stabilizes and buyer confidence returns. A standout 2025 transaction—the sale of the 380‑unit Cyan Southcreek community—signals that capital is flowing back into the market. With bid‑ask spreads tightening and investor optimism rising, Kansas City is entering a period of renewed opportunity for real estate professionals and investors alike.
Florida’s Middle Class Is Being Squeezed Out: Insurance Costs, Rebuilding Struggles, and a Changing Coastline Gallery
